PRZOOM - /newswire/ -
San Diego, CA, United States, 2005/06/07 - Aethlon Medical, Inc. Will Present at the Informed Investors Biotechnology / Healthcare / Pharmaceutical Investor Forum at The Princeton Club of New York on Wednesday, June 15, 2005, 9:05 am ET.
Aethlon Medical, Inc. (OTCBB: AEMD) will present at the following forum:
What: Informed Investors Biotechnology / Healthcare / Pharmaceutical Investor Forum
When: June 15, 2005 @ 9:05 AM Eastern Time
Sponsors: Barron's, The Wall Street Journal, The American Stock Exchange and Business Wire
Keynote Presentations: Lynn Sutherland, M.S., M.B.A. - President,
Sutherland Consulting Dr. Navdeep Jaikaria,
Senior Biotechnology Analyst, Rodman & Renshaw, LLC
Where: The Princeton Club of New York, 15 West 43rd Street., New York City, NY 10036
How to attend: Pre-registration is necessary. To register, contact Cary Loeser, cloeser[.]wilink.com, or 804-327-3407. You may also call Customer Service at 888-301-6618, or register online.
Aethlon Medical is pioneering the development of viral filtration devices to treat drug and vaccine resistant pathogens. The market focus is the treatment of the Human Immunodeficiency Virus (HIV), Hepatitis-C (HCV), and Biological Weapon candidates. Aethlon has an experienced management team, which receives support and guidance from globally recognized science advisors representing the infectious disease, biowarfare, and dialysis industries. Clinical Trials to treat HIV and HCV patients in India are scheduled to begin in the coming months, and U.S. clinical studies are expected to begin later this year.
Source: Aethlon Medical, Inc.